Hakkında
Dr Fahad Ibnshamsah is a highly respected Consultant Medical Oncologist and Internal Medicine Specialist. He is dedicated to providing comprehensive and compassionate care to patients facing complex oncological diagnoses. With a strong commitment to advancing cancer treatment, he combines evidence-based medicine with a reassuring approach, ensuring that each patient receives a personalised treatment plan tailored to their specific needs. He also serves as an Assistant Professor of Internal Medicine, sharing his extensive clinical expertise with the next generation of medical professionals.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Fahad Ibnshamsah
Eğitim ve öğretim
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Onkoloji
Kariyer ve atamalar
-
2021-09–2022-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
SA — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Onkoloji
Mesleki sorumluluk sigortası:
HDI Global · 3,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 956 |
| Annual physical exam | 99395 | 266 |
| Vaccination administration | 90471 | 2,826 |
| Minor procedure (skin) | 17110 | 693 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 dk | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 30 dk | in_clinic | 180.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 5 · i10: 7
-
Long-term follow-up of Onkoloji across SA
DOI: 10.8710/euroclin.2026.0 · PMID: 37979660 · alıntılayan 180
-
Validation of clinical scoring in Onkoloji
DOI: 10.5738/euroclin.2025.1 · PMID: 31282003 · alıntılayan 102
-
Long-term follow-up of Onkoloji across SA
DOI: 10.9519/euroclin.2024.2 · PMID: 33838956 · alıntılayan 16
-
Validation of clinical scoring in Onkoloji
DOI: 10.4283/euroclin.2023.3 · PMID: 39972240 · alıntılayan 162
Davetli konuşmalar
- Practical updates in Onkoloji European Annual Congress (Onkoloji) · Vienna · 2024 · invited
- Single-centre experience in Onkoloji National Society Meeting · Dammam · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Onkoloji — Dammam · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2022 yılından beri
- national college of family doctors — Member · 2022 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2022 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Onkoloji
- Awareness When should you see a onkoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · fahad.ibnshamsah@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
